2020 NCI Alliance for Nanotechnology in Cancer PI Meeting Agenda
Day 1, Thursday, November 5th |
|
10:30 a.m. - 11:00 a.m. |
Welcome and Introduction |
11:00 a.m. – 11:45 a.m. |
Keynote presentation: Smart strategies to improve cancer nanomedicine performance |
Session I: Cancer nano-vaccines and immunotherapy Moderator: Connie Sommers, Ph.D., National Cancer Institute |
|
11:45 a.m. – 12:10 a.m. |
Plant viral nanoparticle-based cancer in situ vaccine |
12:10 p.m. – 12:35 p.m. |
Title TBD |
12:35 p.m. – 12:50 p.m. |
Break (15 minutes) |
12:50 p.m. – 1:05 p.m. |
Map Leukemia-immune Cell Communication with Nanoplasmon Ruler in CAR T-Cell Immunotherapy |
1:05 p.m. – 1:30 p.m |
Cobalt-porphyrin liposomes for cancer epitope immunization and discovery using short, MHC-I, restricted peptides |
1:30 p.m. – 1:55 p.m. |
STING-Activating Nanovaccine for T Cell Immunotherapy of Cancer |
1:55 p.m. – 2:10 p.m. |
Use of Nano-enabled Chemo-immunotherapy for Cancer |
2:10 p.m. – 3:00 p.m. |
Lunch break (50 minutes) |
Session II: Quick-fire talks – updates from CCNEs Moderator: Christina Liu, Ph.D., National Cancer Institute |
|
3:00 p.m. – 4:00 p.m. |
|
Session III: Nanotechnology for COVID-19 applications Moderator: Christopher Hartshorn, Ph.D., National Cancer Institute |
|
4:00 p.m. – 4:30 p.m. |
Title TBD |
4:30 p.m. – 5:00 p.m. |
Title TBD |
5:00 p.m. – 5:15 p.m. |
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19 |
5:15 p.m. – 5:30 p.m. |
Title TBD |
5:30 p.m. – 5:45 p.m. |
Title TBD |
Day 2, Friday, November 6th |
|
Session IV: Priorities for nanomedicine in next 5 years Moderator: Andre Nel, M.D., Ph.D., UC Los Angeles |
|
10:30 a.m. – 12:00 p.m. |
Strategy session: Cancer Immunotherapy and Nanotechnology |
Session V: Quick-fire talks – updates from CCNEs Moderator: Christina Liu, Ph.D., National Cancer Institute |
|
12:00 p.m. – 1:00 p.m. |
|
1:00 p.m. – 1:45 p.m. |
Lunch break (45 minutes) |
Session VI: Nanotechnology and tumor microenvironment Moderator: Piotr Grodzinski, Ph.D., National Cancer Institute |
|
1:45 p.m. – 2:00 p.m. |
Ultrasmall Particle-based Solutions for Modulating the Tumor-Immune Microenvironment and Improving Anti-Tumor Responses |
2:00 p.m. – 2:25 p.m. |
Title TBD |
2:25 p.m. – 2:50 p.m. |
A low pH-activated nanobomb for targeted therapy of triple negative breast cancer with RNA interference |
2:50 p.m. – 3:05 p.m. |
Title TBD |
3:05 p.m. – 3:20 p.m. |
Break (15 minutes) |
3:20 p.m. – 3:35 p.m. |
The Tumor Microenvironment in Nanoparticle Delivery and Function |
3:35 p.m. – 4:00 p.m. |
Tumor Eradication with T-cells Targeted with Multivalent Chemically Self-Assembled Nanorings |
4:00 p.m. – 4:25 p.m. |
Title TBD |
4:25 p.m. – 4:50 p.m. |
Using nanopartilces to modulate tumor metabolism |
4:50 p.m. – 5:10 p.m. |
Closing comments |
5:10 p.m. |
Adjournment |